Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JBP Taiwan is the regional subsidiary of Japan Bio Products Co., Ltd., a world-renowned specialist in placenta-based medicine and biotechnology. The company is primarily recognized for its flagship product, Laennec, a human placenta extract used clinically for the treatment of chronic liver disease and cirrhosis. JBP Taiwan also markets a variety of placenta-derived aesthetic products and nutritional supplements, leveraging proprietary extraction and safety technologies. Their business model focuses on the distribution of ethical pharmaceuticals and the promotion of regenerative medicine applications within the Taiwanese healthcare market. The company also provides specialized medical devices, such as ultra-thin nanoneedles, to enhance patient comfort during clinical procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JBP Taiwan.